Katharina Leonards

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Dendritic Cells

Gene Expression

Small Cell Lung Cancer

Top Venues

Current oncology (Toronto, Ont.)

The Journal of pathology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Franziska C Adam, Jakub Szybinski, Joerg P Halter, Nathan Cantoni, Friedel Wenzel, Katharina Leonards, Sime Brkic, Jakob R Passweg, Ivo Touw, Julia E Maxson, Sara C Meyer
Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia. Current oncology (Toronto, Ont.) 29 (2) (2022)
Sime Brkic, Simona Stivala, Alice Santopolo, Jakub Szybinski, Sarah Jungius, Jakob R Passweg, Dimitrios Tsakiris, Stefan Dirnhofer, Gregor Hutter, Katharina Leonards, Heidi E L Lischer, Matthias S Dettmer, Benjamin G Neel, Ross L Levine, Sara C Meyer
Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy. Leukemia 35 (10) (2021)
Katharina Leonards, Marwa Almosailleakh, Samantha Tauchmann, Frederik Otzen Bagger, Cécile Thirant, Sabine Juge, Thomas Bock, Hélène Méreau, Matheus Filgueira Bezerra, Alexandar Tzankov, Robert Ivanek, Régine Losson, Antoine H F M Peters, Thomas Mercher, Juerg Schwaller
Nuclear interacting SET domain protein 1 inactivation impairs GATA1-regulated erythroid differentiation and causes erythroleukemia. Nature communications 11 (1) (2020)
Ilaria Alborelli, Katharina Leonards, Sacha I Rothschild, Laura P Leuenberger, Spasenija Savic Prince, Kirsten D Mertz, Severin Poechtrager, Martin Buess, Alfred Zippelius, Heinz Läubli, Jasmin Haegele, Markus Tolnay, Lukas Bubendorf, Luca Quagliata, Philip M Jermann
Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer. The Journal of pathology 250 (1) (2019)